Cargando…
RNA-Seq Accurately Identifies Cancer Biomarker Signatures to Distinguish Tissue of Origin()
Metastatic cancer of unknown primary (CUP) accounts for up to 5% of all new cancer cases, with a 5-year survival rate of only 10%. Accurate identification of tissue of origin would allow for directed, personalized therapies to improve clinical outcomes. Our objective was to use transcriptome sequenc...
Autores principales: | Wei, Iris H., Shi, Yang, Jiang, Hui, Kumar-Sinha, Chandan, Chinnaiyan, Arul M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240918/ https://www.ncbi.nlm.nih.gov/pubmed/25425966 http://dx.doi.org/10.1016/j.neo.2014.09.007 |
Ejemplares similares
-
Landscape of gene fusions in epithelial cancers: seq and ye shall find
por: Kumar-Sinha, Chandan, et al.
Publicado: (2015) -
TACO produces robust multi-sample transcriptome assemblies from RNA-seq
por: Niknafs, Yashar S., et al.
Publicado: (2016) -
Classification and Selection of Biomarkers in Genomic Data Using LASSO
por: Ghosh, Debashis, et al.
Publicado: (2005) -
Gene signatures from scRNA‐seq accurately quantify mast cells in biopsies in asthma
por: Jiang, Jian, et al.
Publicado: (2020) -
Identification of Novel PGR-NR4A3 Fusion in Extraskeletal Myxoid Chondrosarcoma and Resultant Patient Benefit From Tamoxifen Therapy
por: Wilbur, H. Catherine, et al.
Publicado: (2022)